Skip to content

Cell Source, Inc.

CLCS

CIK 0001569340

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$5.66M
+15.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.16
+17.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$2.11M
Q1 May 2026
Cash
$21.99K
Q1 May 2026
Total Debt
$50K
Q1 May 2026
Shares Outstanding
67.95M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings